| Product Code: ETC10772414 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Australia Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.7 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Australia Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease (PAD) in Australia |
4.2.2 Technological advancements in drug-eluting devices for peripheral interventions |
4.2.3 Rising demand for minimally invasive procedures in peripheral interventions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-eluting devices |
4.3.2 High cost associated with drug-eluting devices and procedures |
4.3.3 Limited reimbursement policies for peripheral intervention drug-eluting devices |
5 Australia Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Australia Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 Australia Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031F |
6.1.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2021 - 2031F |
6.1.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2021 - 2031F |
6.1.7 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031F |
6.2 Australia Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2021 - 2031F |
6.2.3 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2021 - 2031F |
6.2.4 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2021 - 2031F |
6.2.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2021 - 2031F |
6.2.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2021 - 2031F |
6.3 Australia Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.3.3 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031F |
6.3.4 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2021 - 2031F |
6.3.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2021 - 2031F |
6.4 Australia Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2021 - 2031F |
6.4.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2021 - 2031F |
6.5 Australia Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2021 - 2031F |
6.5.3 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2021 - 2031F |
6.5.4 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2021 - 2031F |
6.5.5 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031F |
6.5.6 Australia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
7 Australia Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 Australia Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 Australia Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 Australia Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Average procedure time for drug-eluting device interventions |
8.2 Number of research and development partnerships for innovative drug-eluting devices |
8.3 Adoption rate of drug-eluting devices in peripheral interventions |
8.4 Average length of hospital stay post drug-eluting device procedure |
8.5 Number of clinical trials evaluating the efficacy of drug-eluting devices in Australia |
9 Australia Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 Australia Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Australia Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
9.3 Australia Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Australia Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Australia Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 Australia Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here